TUMORGEN MDX Trademark

Trademark Overview


On Friday, June 13, 2014, a trademark application was filed for TUMORGEN MDX with the United States Patent and Trademark Office. The USPTO has given the TUMORGEN MDX trademark a serial number of 86309711. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, December 31, 2021. This trademark is owned by TumorGen MDx, LLC. The TUMORGEN MDX trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific research services to identify isolate and capture rare cells and rare cell clusters, to aid in the study of cell signaling, cell growth and cell apoptosis processes
tumorgen mdx

General Information


Serial Number86309711
Word MarkTUMORGEN MDX
Filing DateFriday, June 13, 2014
Status710 - CANCELLED - SECTION 8
Status DateFriday, December 31, 2021
Registration Number4763264
Registration DateTuesday, June 30, 2015
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, April 14, 2015

Trademark Statements


Description of MarkThe mark consists of the figure of a segment of DNA helix with four circles located in the top left corner of the helix. The words "TUMORGEN" and "MDX" in stylized characters are located underneath the figure.
Pseudo MarkTUMOR GENE MDX
Indication of Colors claimedColor is not claimed as a feature of the mark.
Disclaimer with Predetermined Text"MDX"
Goods and ServicesScientific research services to identify isolate and capture rare cells and rare cell clusters, to aid in the study of cell signaling, cell growth and cell apoptosis processes

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, December 31, 2021
Primary Code042
First Use Anywhere DateWednesday, March 19, 2014
First Use In Commerce DateWednesday, March 19, 2014

Trademark Owner History


Party NameTumorGen MDx, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressCardiff by the Sea, CA 92007

Party NameTumorGen MDx, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressCardiff by the Sea, CA 92007

Party NameTumorGen MDx, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressCardiff by the Sea, CA 92007

Trademark Events


Event DateEvent Description
Friday, December 31, 2021CANCELLED SEC. 8 (6-YR)
Tuesday, June 30, 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, June 30, 2015REGISTERED-PRINCIPAL REGISTER
Tuesday, April 14, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 14, 2015PUBLISHED FOR OPPOSITION
Wednesday, March 25, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, March 9, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, March 5, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, February 27, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, February 27, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 19, 2015ASSIGNED TO LIE
Thursday, February 12, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, September 30, 2014NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, September 30, 2014NON-FINAL ACTION E-MAILED
Tuesday, September 30, 2014NON-FINAL ACTION WRITTEN
Tuesday, September 23, 2014ASSIGNED TO EXAMINER
Wednesday, June 25, 2014NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, June 24, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, June 17, 2014NEW APPLICATION ENTERED IN TRAM